• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Everolimus Eluting Stent-induced Early Giant Multiple Coronary Artery Aneurysm Formation.

作者信息

Akçay Murat, Çoksevim Metin

机构信息

Department of Cardiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye.

出版信息

Anatol J Cardiol. 2024 Jul 23;28(9):E-29-30. doi: 10.14744/AnatolJCardiol.2024.4623.

DOI:10.14744/AnatolJCardiol.2024.4623
PMID:39039991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11426399/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502f/11426399/01c73e260afc/ajc-28-9-E-29_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502f/11426399/01c73e260afc/ajc-28-9-E-29_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502f/11426399/01c73e260afc/ajc-28-9-E-29_f001.jpg

相似文献

1
Everolimus Eluting Stent-induced Early Giant Multiple Coronary Artery Aneurysm Formation.依维莫司洗脱支架诱导的早期巨大多发性冠状动脉瘤形成。
Anatol J Cardiol. 2024 Jul 23;28(9):E-29-30. doi: 10.14744/AnatolJCardiol.2024.4623.
2
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents.经依维莫司洗脱支架置入术后冠状动脉瘤的病例系列研究及与西罗莫司洗脱支架的比较。
BMC Cardiovasc Disord. 2022 Feb 17;22(1):60. doi: 10.1186/s12872-022-02503-1.
3
Coronary aneurysm formation in a patient early after everolimus-eluting stent implantation.
J Invasive Cardiol. 2008 May;20(5):E174-5.
4
Giant Coronary Artery Aneurysm Due to Implantation of Drug-Eluting Stent.药物洗脱支架植入所致巨大冠状动脉瘤
Cureus. 2024 Jan 10;16(1):e52004. doi: 10.7759/cureus.52004. eCollection 2024 Jan.
5
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.多部位、多血管病变患者中应用依维莫司洗脱支架和紫杉醇洗脱支架的对比：SPIRIT III 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统（EECSS）的 XIENCE V 血管内介入器械的临床评估）和 SPIRIT IV 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统的 XIENCE V 血管内介入器械的临床评估）随机临床试验。
JACC Cardiovasc Interv. 2010 Dec;3(12):1229-39. doi: 10.1016/j.jcin.2010.09.014.
6
A case of early development of giant coronary artery aneurysms after drug-eluting stents implantation: An unpredictable menace.药物洗脱支架植入术后早期发生巨大冠状动脉瘤1例：一种不可预测的威胁。
Interv Med Appl Sci. 2017 Mar;9(1):47-50. doi: 10.1556/1646.9.2017.1.10.
7
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.依维莫司和紫杉醇洗脱支架置入术后 3 年的临床随访：来自 SPIRIT II（依维莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估）和 SPIRIT III（依维莫司洗脱冠状动脉支架系统[EECSS]治疗初发冠状动脉病变患者的临床评估）随机试验的汇总分析。
JACC Cardiovasc Interv. 2010 Dec;3(12):1220-8. doi: 10.1016/j.jcin.2010.07.017.
8
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).3 年临床随访结果：新一代西罗莫司洗脱冠状动脉支架系统（XIENCE V）治疗初发冠状动脉病变的 SPIRIT II 临床试验（新一代西罗莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估）。
JACC Cardiovasc Interv. 2009 Dec;2(12):1190-8. doi: 10.1016/j.jcin.2009.10.002.
9
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).在冠状动脉疾病中，依维莫司洗脱支架与紫杉醇洗脱支架的荟萃分析：SPIRIT 临床试验计划的最终 3 年结果（在治疗新发病变的患者中，使用依维莫司洗脱冠状动脉支架系统治疗的西里斯 V 依维莫司洗脱冠状动脉支架系统的临床评估）。
JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005.
10
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).冠状动脉疾病中的新一代药物洗脱支架：聚焦依维莫司洗脱支架（Xience V）。
Vasc Health Risk Manag. 2008;4(1):31-8. doi: 10.2147/vhrm.2008.04.01.31.

本文引用的文献

1
Early-Period Coronary Aneurysm Formation After Sirolimus-Eluting Stent Implantation.西罗莫司洗脱支架植入术后早期冠状动脉瘤形成
Anatol J Cardiol. 2023 Nov 1;27(11):E34-E35. doi: 10.14744/AnatolJCardiol.2023.3622. Epub 2023 Oct 4.
2
Surgical management of drug-eluting stent associated coronary artery aneurysms: a case series.药物洗脱支架相关冠状动脉瘤的外科治疗：病例系列
Indian J Thorac Cardiovasc Surg. 2023 Mar;39(2):182-185. doi: 10.1007/s12055-022-01457-5. Epub 2023 Jan 3.
3
Everolimus-Eluting Stent Causing Coronary Artery Aneurysm in 7 Days: 3D-OCT Findings and Management.
J Invasive Cardiol. 2020 Nov;32(11):E301-E302. doi: 10.25270/jic/20.00025.
4
Very Early Coronary Artery Aneurysm After Primary Percutaneous Coronary Intervention in Patient With HIV and Thrombophilia.HIV与血栓形成倾向患者经皮冠状动脉介入治疗后极早期冠状动脉瘤
Cardiol Res. 2019 Oct;10(5):312-317. doi: 10.14740/cr907. Epub 2019 Oct 4.
5
Clinical outcomes of patients with coronary artery aneurysm after the first generation drug-eluting stent implantation.第一代药物洗脱支架植入术后冠状动脉瘤患者的临床转归。
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):E235-E245. doi: 10.1002/ccd.27429. Epub 2017 Nov 22.
6
Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment.冠状动脉瘤：流行病学、病理生理学、诊断及治疗综述
Front Cardiovasc Med. 2017 May 5;4:24. doi: 10.3389/fcvm.2017.00024. eCollection 2017.
7
Multiple coronary micro-aneurysm formation after drug-eluting stent implantation.
Hellenic J Cardiol. 2016 May-Jun;57(3):191-193. doi: 10.1016/j.hjc.2015.12.002. Epub 2016 Jun 25.
8
Early aneurysm formation after everolimus-eluting stent implantation.依维莫司洗脱支架植入术后早期动脉瘤形成。
Circ Cardiovasc Interv. 2014 Apr;7(2):266-7. doi: 10.1161/CIRCINTERVENTIONS.113.000945.
9
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?西罗莫司洗脱支架所致局部超敏反应和迟发性冠状动脉血栓形成：我们应谨慎对待吗？
Circulation. 2004 Feb 17;109(6):701-5. doi: 10.1161/01.CIR.0000116202.41966.D4. Epub 2004 Jan 26.